Robert Taylor has been appointed CEO of AccuImage, a South San Francisco, CA-based developer of 3-D and 4-D post-processing and connectivity software for PACS and other medical imaging applications. Taylor, previously COO of AccuImage, replaces Allen
Robert Taylor has been appointed CEO of AccuImage, a South San Francisco, CA-based developer of 3-D and 4-D post-processing and connectivity software for PACS and other medical imaging applications. Taylor, previously COO of AccuImage, replaces Allen Poirson, who resigned from the company.
AccuImage expects Taylors appointment to help expedite AccuImages current product development efforts, which include AccuView, a 3-D workstation, and eStation 3D, a Web-based workstation for PACS and teleradiology. Taylor will be responsible for moving AccuView into the marketplace and overseeing final development of eStation 3D, according to Douglas Boyd, chairman of AccuImage. Both products incorporate AccuImages proprietary software platform, which provides review and analysis tools for CT, MR, and ultrasound imaging and enables the transfer of medical images across the Internet and hospital intranets.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.